Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Gossamer Bio | 2023 | Post Ipo Equity | $212.0M | San Diego |
| Mozart Therapeutics | 2023 | Series A | $25.0M | Seattle |
| Bitterroot Bio | 2023 | Series A | $145.0M | Palo Alto |
| OncoResponse | 2023 | Series D | $14.0M | Seattle |
| CREATE Medicines | 2023 | Series A | $73.0M | Cambridge |
| Boundless Bio | 2023 | Series C | $100.0M | La Jolla |
| Orbital Therapeutics | 2023 | Series A | $270.0M | Cambridge |
| Recuro Health | 2023 | Series B | $47.0M | Richardson |
| Paratus Sciences | 2023 | Series A | $100.0M | New York |
| Aera Therapeutics | 2023 | Series B | $193.0M | Boston |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Gossamer Bio | Post Ipo Equity | $212.0M | San Diego, United States |
| 102 | Mozart Therapeutics | Series A | $25.0M | Seattle, United States |
| 103 | Bitterroot Bio | Series A | $145.0M | Palo Alto, United States |
| 104 | OncoResponse | Series D | $14.0M | Seattle, United States |
| 105 | CREATE Medicines | Series A | $73.0M | Cambridge, United States |
| 106 | Boundless Bio | Series C | $100.0M | La Jolla, United States |
| 107 | Orbital Therapeutics | Series A | $270.0M | Cambridge, United States |
| 108 | Recuro Health | Series B | $47.0M | Richardson, United States |
| 109 | Paratus Sciences | Series A | $100.0M | New York, United States |
| 110 | Aera Therapeutics | Series B | $193.0M | Boston, United States |
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
CREATE Medicines is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Recuro Health offers a holistic suite of virtual care services and supplemental benefits.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Protillion Biosciences specializes in the design and development of protein-based drugs.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Mindstrong is a virtual mental health platform.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Happy Health is a mission-driven technology company
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Feelmore Labs is an innovative health & wellness technology company.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Singleron Biotechnologies is an innovative molecular diagnostic company.
ARCH Venture Partners has invested in 156 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Biopharma. The firm invests across 28 different industry categories.
Among tracked funding rounds, Orbital Therapeutics received $270.0M in a Series A round. ARCH Venture Partners's total known invested capital is $14.3B.
ARCH Venture Partners's average investment size is $119.8M across its portfolio of 156 companies.
Recent ARCH Venture Partners portfolio additions include Gossamer Bio, Mozart Therapeutics, Bitterroot Bio, OncoResponse, CREATE Medicines. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors